Month in review
January 2026: UK medicine shortages
Every change to the UK medicines supply that entered the public record in January 2026 — 14 events across 5 categories, each linked to its source. A fixed, citable snapshot: this page shows January 2026 and will not change as later months are added.
New supply notifications · 4
| Date | Medicine / notice | Reference |
|---|---|---|
| 28 Jan 2026 | Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches | MSN/2026/004 |
| 15 Jan 2026 | Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets | MSN/2026/002 |
| 13 Jan 2026 | Discontinuation of Subutex® and Suboxone® tablets | — |
| 12 Jan 2026 | Medicine Supply Notification: Co-codamol 30mg/500mg tablets | MSN/2026/001 |
Safety alerts · 1
| Date | Medicine / notice | Reference |
|---|---|---|
| 29 Jan 2026 | National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited | NatPSA/2026/002/MHRA |
Notification updates · 2
| Date | Medicine / notice | Reference |
|---|---|---|
| 15 Jan 2026 | Discontinuation of Subutex® and Suboxone® tablets | — |
| 08 Jan 2026 | Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches – updated | MSN/2025/062 |
SSP extensions · 3
| Date | Medicine / notice | Reference |
|---|---|---|
| 30 Jan 2026 | SSP60 – Creon® 10000 gastro-resistant capsules further extended — now to 17 Apr 2026 | SSP060 |
| 16 Jan 2026 | SSP60 – Creon® 10000 gastro-resistant capsules further extended — now to 30 Jan 2026 | SSP060 |
| 16 Jan 2026 | SSP61 – Creon® 25000 gastro-resistant capsules further extended — now to 17 Apr 2026 | SSP061 |
Discontinuations · 4
| Date | Medicine / notice | Reference |
|---|---|---|
| 15 Jan 2026 | Medicine Supply Notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets | MSN/2026/002 |
| 15 Jan 2026 | Discontinuation of Subutex® and Suboxone® tablets | — |
| 13 Jan 2026 | Discontinuation of Subutex® and Suboxone® tablets | — |
| 08 Jan 2026 | Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches – updated | MSN/2025/062 |
Cite as: “UK Shortage Index — January 2026 in review, ShortageSignal (shortagesignal.co.uk/uk-shortage-index/2026-01), by Doctor Data Ltd.” Coverage is England-first and reflects notifications relayed publicly; the archive window means very early months may under-count resolved notices. Not an official NHS or DHSC service.